Cullinan Therapeutics, Inc. (CGEM)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
12. 93
-1.07
-7.6429%
$
954.44M Market Cap
- P/E Ratio
- Div Yield
1.12M Volume
- Eps
$ 14
Previous Close 
Want to track CGEM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cullinan Therapeutics, Inc. (CGEM) Statistics
Valuation metrics
Market Cap 954.44M
Enterprise value 718.08M
Trailing P/E (ttm) -3.84
Forward P/E -
PEG ratio -1.22
Price/Sales (ttm) -
Price/Book (mrq) 2.47
Enterprise Value/Revenue -
Enterprise Value/EBITDA -3.45
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 809.34K
Average volume (90 days) 891.43K
Price summary
52-Week low 6.73
52-Week high 23.19
Beta -
50-Day moving average 18.14
200-Day moving average 16.83
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 2:1
Last split Date 31 Aug 2009
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.56%
Return on equity -0.53%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.33
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.44
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 8.42%
Book value per share (mrq) 5.23
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
